Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04253587 · ClinicalTrials.gov registry record · NA
Wayfinding Intervention in High-Fidelity Long-Term Memory
A NA study of Mild Cognitive Impairment and Long-Term Memory Decline, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04253587: Completed NA study of Mild Cognitive Impairment and Long-Term Memory Decline, sponsored by University of California, San Francisco.
NCT04253587 is a NA study of Mild Cognitive Impairment and Long-Term Memory Decline that has completed, run by University of California, San Francisco. The registered enrollment target is 50 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04253587, a NA study of Mild Cognitive Impairment and Long-Term Memory Decline, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Therapeutic treatment is yet available for declining memory, which is an impairment affecting the quality of life for many older adults and patients with cognitive impairment. Cognitive training with an immersive video game promises to drive hippocampal-cortical plasticity and associated gains that can restore memory capability or provide therapeutic treatment for memory deficits.
Primary Outcome
Mnemonic discrimination task testing recognition memory for common objects, as reported in scores on a scale of the Lure Discrimination Index ranging from 0.00 to 1.00 where higher values show better performance.
Conditions Studied
Interventions
- DEVICE LabyrinthVR
- DEVICE Placebo Games
- DEVICE Coherence
- DEVICE Tablet
Study Locations (1)
California
- UCSF Mission Bay - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2021-12-15 |
| Phase | NA |
What the finished NCT04253587 record still lists
NCT04253587 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 4 interventions - of which LabyrinthVR is the first listed.
NCT04253587 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04253587 about?
NCT04253587 is a clinical study titled "Wayfinding Intervention in High-Fidelity Long-Term Memory". Therapeutic treatment is yet available for declining memory, which is an impairment affecting the quality of life for many older adults and patients with cognitive impairment. Cognitive training with an immersive video game promises to drive hippocampal-cortical plasticity and associated gains that ...
What is the current status of trial NCT04253587?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-10-01. Estimated completion is 2021-12-15.
What conditions does trial NCT04253587 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Long-Term Memory Decline.
What interventions are being tested in trial NCT04253587?
The interventions under investigation include: LabyrinthVR (DEVICE), Placebo Games (DEVICE), Coherence (DEVICE), Tablet (DEVICE).
Who is sponsoring clinical trial NCT04253587?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04253587 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04253587's enrollment target sits among peer trials
50 140th of 205 higher than 62 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Impact of Intensive Computerized Cognitive Training
RECRUITING · NA
-
Multimodal Investigation of Neural Plasticity
RECRUITING · NA
-
GAMES Intervention in MCI (Mild Cognitive Impairment)
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI